FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

FDA Proposes 1,003 Devices Exempt from 510(k)

Federal Register notice: FDA announces a list of 1,003 Class 2 devices that the agency is proposing to exempt or partially exempt from premarket notif...

Human Drugs

FDA Lifts Sun Pharma Mohali Import Alert

FDA says it is lifting an import alert placed on Sun Pharmas Mohali drug manufacturing facility in 2013.

Human Drugs

CGMP Violations, Import Alert at Badrivishal Chemicals

FDA warns Indias Badrivishal Chemicals & Pharmaceuticals about CGMP deviations in its manufacturing of active pharmaceutical ingredients.

Human Drugs

Lumis Inspection Finds CGMP Deviations

FDA warns Chinas Lumis Global Pharmaceuticals about CGMP deviations and misbranding violations in its manufacturing of active pharmaceutical ingredien...

False Claims Act Expands in 2016: Hogan Lovells

Hogan Lovells attorneys says 2016 was a year of expansion for the False Claims Act, netting the government nearly $5 billion in recoveries, and there ...

Medical Devices

FDA Says Medtronic Pump Recall is Class 1

FDA says the Medtronic recall of SynchroMed implantable infusion pumps due to a software problem that could cause a drug overdose or under-dose is Cla...

Federal Register

Comments Sought on Proposed Patient Engagement Office

Federal Register notice: FDA establishes a public docket to accept comments on its ongoing efforts to enhance mechanisms for patient engagement at the...

Federal Register

FDA Joint Panel Meeting to Discuss Pain Drug

Federal Register Notice: FDA announces a 4/5 joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Ri...

Human Drugs

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that cite Badrivishal Chemicals & Pharmaceuticals and Lumis Global Pharmaceuticals Co.

Human Drugs

FDA Partial Hold on Karyopharms Selinexor

FDA places a partial clinical hold on Karyopharm Therapeutics clinical trials for selinexor (KPT-330) due to incomplete information contained in an ex...